## Abstract A few caseβcontrol studies have been published on familial risks in esophageal cancer. Reliable data on familial risks are needed for prevention and clinical decisions. We used the nationβwide Swedish FamilyβCancer Database on 10.1 million individuals and close to 6000 esophageal cancer
Familial carcinoid tumors and subsequent cancers: A nation-wide epidemiologic study from Sweden
β Scribed by Kari Hemminki; Xinjun Li
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- French
- Weight
- 74 KB
- Volume
- 94
- Category
- Article
- ISSN
- 0020-7136
- DOI
- 10.1002/ijc.1473
No coin nor oath required. For personal study only.
β¦ Synopsis
Carcinoids are rare neuroendocrine tumors, mainly located in the bowel, stomach and lung. Familial risks in carcinoid tumours are not well known apart from multiple endocrine neoplasia 1 (MEN1). We used the nation-wide Swedish Family-Cancer Database on 10.1 million individuals for assessment. Carcinoid tumors were retrieved from the Cancer Registry covering the years 1958 -1998. The offspring generation, aged 0 -66 years, accumulated 190 million personyears at risk. The age-adjusted incidence rates were 0.76 for men and 1.29/100,000 for women. Standardized incidence ratios (SIRs) were calculated for offspring when their parents had a carcinoid or any other cancer. When parents presented with carcinoids, SIRs for offspring were 4.35 (n β«Ψβ¬ 8, 95% CI 1.86 -7.89) for small intestinal and 4.65 (n β«Ψβ¬ 4, 95% CI 1.21-10.32) for colon carcinoids. If both offspring and parents presented with small intestinal carcinoids, the SIR was 12.31 (n β«Ψβ¬ 4, 95% CI 3.20 -27.34). Offspring carcinoids were also increased if parents presented with bladder and endocrine gland tumors, the latter association probably partially due to MEN1. Risks for second cancers were increased, particularly at sites where familial risks were found, including carcinoids in the small intestine.
π SIMILAR VOLUMES
## Abstract Familial risk of pancreatic cancer has been mainly assessed through caseβcontrol studies based on reported but not medically verified cancers in family members. We used the nationwide Swedish FamilyβCancer Database on 10.2 million individuals and 21,000 pancreatic cancers to calculate s
There is a familial aggregation of prostate cancer, and 5 to 10% of all prostate cancers are estimated to be inherited in an autosomal-dominant mode. A population-based cohort study was performed in order to study familial prostate cancer and associated malignancies. A nation-wide register cohort st